HCPCS S1034 is officially defined as "Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices." No tracked policy changes reference HCPCS S1034 yet. New payer updates are added daily, so check back soon or create a free alert to be notified the moment a change affects this code.
No tracked policy changes match this filter yet. New policies are added daily.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.